Q32 Bio (QTTB) announced the appointment of Adrien Sipos as interim chief medical officer. Sipos succeeds Jason Campagna who will be departing the company. Prior to joining Q32 Bio, Sipos served as president and chief medical officer at Praxico.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB: